Abstract The advancement of Bkidney-on-a-chip^plat-forms-submillimeter-scale fluidic systems designed to recapitulate renal functions in vitro-directly impacts a wide range of biomedical fields, including drug screening, cell and tissue engineering, toxicity testing, and disease modeling. To fabricate kidney-on-a-chip technologies, researchers have primarily adapted traditional micromachining techniques that are rooted in the integrated circuit industry; hence the term Bchip.^A significant challenge, however, is that such methods are inherently monolithic, which limits one's ability to accurately recreate the geometric and architectural complexity of the kidney in vivo. Better reproduction of the anatomical complexity of the kidney will allow for more instructive modeling of physiological and pathophysiological events. Emerging additive manufacturing or Bthree-dimensional (3D) printingt echniques could provide a promising alternative to conventional methodologies. In this article, we discuss recent progress in the development of both kidney-on-a-chip platforms and state-of-the-art submillimeter-scale 3D printing methods, with a focus on biophysical and architectural capabilities. Lastly, we examine the potential for 3D printing-based approaches to extend the efficacy of kidney-on-a-chip systems.
Introduction
Although the human kidney is characterized by significant biophysical, architectural, and physiological complexity, two-dimensional (2D) models with quasi-static fluidic conditions represent the predominant method by which kidney cell functions have been investigated in vitro. In recent years, researchers have made considerable efforts to mimic key features of in vivo organ systems in order to promote biologically relevant cell and/or tissue-level behavior in vitro [1] . Through the use of bioengineered microfluidic cell culture platformsa class of microdevices termed Borgan-on-a-chip^-researchers have developed controlled microenvironments, which, coupled with compartmentalization, provide an in vitro means of simulating a number of in vivo chemical, mechanical, and structural factors [2] . Rather than recreating entire organ systems, such platforms consist of the minimal cell or tissue interactions required to model specific functions of a representative organ [3] . For example, Bkidney-on-a-chipp latforms typically comprise a singular monolayer of kidney epithelial cells within a microfluidic compartment designed to reproduce physiologic levels of fluidic shear stress [4] . One caveat to using monolithic microfabrication methods to construct kidney-on-a-chip (and organ-on-a-chip) systems is that the geometric/architectural versatility is inherently limited [5] . Thus, prior efforts have focused on mimicking organ processes in the absence of 3D physiologic structures [6] . A critical uncertainty associated with planar models, however, is the potential impact of multiple scales of kidney architecture (e.g., local and global tubule curvature, tubule-tubule, tubule-interstitial, and tubule-vasculature interactions, etc.) on cell and tissue functionalities [7] . To investigate such fundamental biological questions, new in vitro methodologies are required to better mimic the biological architectures of in vivo renal systems. In particular, emerging 3D printing technologies that afford submillimeter and submicron-scale precision offer distinctive potential for the development of kidney-on-achip platforms [8] . In this manuscript, we describe the state of the art for kidney-on-a-chip and 3D printing technologies, and future directions in which the two approaches intersect.
Organ-on-a-Chip Platforms
The development of microfluidic systems for cell and tissue culture has traditionally relied on micromachining technologies [9] . Microscale domains provide considerable scalinginduced benefits for biological applications, including rapid diffusion times [10] , low reagent volumes [11] , laminar flow profiles [12] , precision cell handling [13, 14] , high control of microenvironmental conditions [15] , and biologically relevant length scales [16] [17] [18] . At present, microfluidic devices are predominantly constructed using a technique known as Bsoft lithography^ [ 19 ] . E x t e n d i n g p r i o r e l a s t o m e r i c microreplication methods [20] , Duffy and Whitesides et al. introduced a protocol for fabricating enclosed microchannels using the silicone elastomer, poly(dimethylsiloxane) (PDMS) [21] . Generally, single-layer microfluidic device manufacturing via soft lithography consists of six key steps: (i) photoresist is spin-coated onto a silicon wafer, (ii) microfeatures are photolithographically defined, (iii) the photoresist is chemically developed, which removes undesired photoresist, (iv) uncured PDMS is poured onto the developed wafer, which serves as a negative master, (v) after curing, the molded PDMS is removed, and individual devices are manually cut and punched with inlet/outlet ports, and (vi) PDMS devices are bonded to substrates (e.g., PDMS or glass) [22] [23] [24] . This protocol can be adapted or repeated to construct microfluidic devices with multiple layers and/or levels-a process termed Bmultilayer soft lithography^ [25, 26] . In addition, porous membranes can be incorporated into multilayer systems to promote interactions between separate compartments [27] . These methodologies have served as a fundamental basis for the majority of current organ-on-a-chip platforms.
Although a variety of microfluidic approaches were initially created to model organ systems in vitro, such as the liver [28] [29] [30] [31] [32] and lung [33] , a critical point in the evolution of organ-on-a-chip technologies was the introduction of a multilayer soft lithography-based Blung-on-a-chip^by Huh and Ingber et al. [34] . To fabricate the system, first, a thin PDMS layer is punched with holes to serve as a porous membrane [34] [35] [36] . Thereafter, two micromolded PDMS layers-each with three recessed microchannels-are bonded on opposite sides of the porous PDMS membrane. Lastly, the membrane is selectively etched in the side channels, resulting in a system with (i) two side chambers and (ii) an upper and lower chamber separated by the remaining porous membrane. Although the fabrication protocol is relatively time and labor-intensive, this lung-on-a-chip architecture provides several advantages for biological studies [34] [35] [36] . In particular, two distinct cell monolayers can be co-cultured on opposite sides of the intervening porous membrane to reconstitute physiologic tissuetissue interfaces [33, 34] . Due to the compartmentalized microchannels, the upper and lower chambers can be infused with different fluids (e.g., cell media or air) to apply fluidic shear stress and deliver biomolecules, suspended cells, and/or drug candidates to cell monolayers independently [33] [34] [35] [36] . In addition, vacuum can be applied to the side chambers to induce elastic deformation (i.e., physical stretching) of the porous membrane, thereby stimulating seeded cells with substrate-based mechanical cues [34] [35] [36] . For the lung-on-achip device, cyclical vacuum loading (and therefore, cyclical mechanical strain) was applied to the modeled alveolarcapillary membrane interface to recreate physiologic breathing movements [34, 35] .
The lung-on-a-chip methodology has been modified to model additional organ functions, such as the peristaltic motions of the human intestine [37, 38] . Additionally, many groups have also utilized multilayer, membrane-based methodologies [27, 33] to examine a number of other physiological systems, such as the blood-brain barrier [39] [40] [41] and bone marrow [42] . In particular, investigators have designed a wide range of microfluidic platforms to recapitulate renal functions in vitro [43, 44, 45••, 46-48] .
Kidney-on-a-Chip
The ability to accurately identify nephrotoxic agents during the pre-clinical testing stage would enable earlier discontinuation of drug development with a particular therapeutic agent and modification to maintain efficacy with less or no kidney toxicity [49] [50] [51] . Early recognition likely will reduce the nearly 20 % of nephrotoxicity-based drug attrition in phase 3 clinical trials, saving substantial development time and cost [52] . For disease modeling, enhanced precision and experimental controls associated with in vitro testing could enable new insights into kidney disease mechanisms, while providing a promising means to screen new therapies [53, 54] . Consequently, investigators have focused on developing improved in vitro models that will mimic cellular responses in vivo and retain renal cellular functionalities. During drug discovery, the industry standard for pre-clinical screening remains toxicity testing of 2D human cell cultures under quasi-static fluidic conditions, such as in petri dishes and multiwell plates (Fig. 1a) . Despite their predominance, such testing methods lack critical microenvironmental stimuli to effectively mimic in vivo conditions [55] .
At present, the majority of kidney-on-a-chip platforms rely on three primary architectures: (i) single-layer microfluidic systems (Fig. 1b) , (ii) multilayer microfluidic systems comprised of two chambers separated by a permeable membrane (Fig. 1c) , and (iii) systems comprised of a singular, straight tubular structure (Fig. 1d) . These device designs have enabled researchers to investigate and reconstitute several functions of separate nephron segments (Table 1) .
Single-Layer Microfluidic Systems
Compared to their multilayer counterparts, single-layer microfluidic devices (Fig. 1b) benefit from lower manufacturing costs, time, and labor, which have made such systems attractive for cellular studies. To model kidney epithelial cells, Huang and Wu et al. created a single-layer microfluidic system for co-culturing Madin-Darby canine kidney (MDCK) epithelial cells with collagen gel-embedded adipose stem cells (ASCs) [56] . There was a 35 % increase in cellular height (with columnar shape), promotion of cilia formation, and increased Na/K ATPase expression [56] . It should be recognized, however, that MDCK cells have characteristics of the distal nephron, which make up a much smaller part of the tubule than does the proximal tubule (which comprises approximately 90 % of the mass of the kidney cortex). Zhou, Lin, and Qin et al. developed a single-layer architecture to replicate proteinuric nephropathy and investigate changes in immortalized proximal tubular epithelial cells (HK-2) where they express characteristics of mesenchymal cells and become dedifferentiated -behavior often associated with renal interstitial fibrosis [57] . In response to serum proteins and C3a alone, HK-2 cells either underwent apoptosis or adopted a mesenchymal phenotype; however, such effects were not observed in response to heat-inactivated serum [57] . Frohlich, Zhang, and Charest adapted the single-layer approach by modifying the bottom substrate with microgrooves aligned in the direction of microfluidic flow [58] . The combination of surface topography and fluidic shear stress not only promoted cell alignment in the direction of the groove lines and flow, but also enhanced tight junction formation for seeded HK-2 cells [58] . In general, improved physiologic behavior of kidney cells in response to applied fluidic shear stress was consistently found by multiple groups in many experiments [56] [57] [58] .
Multilayer Microfluidic Systems
One of the first multilayer microfluidic devices to be used for modeling renal functions was published by Jang and Suh [43] . Designed to recapitulate functions of the collecting duct, the Fig. 1 Conceptual illustrations of (a-d) kidney epithelial cell testing platform architectures and (e-g) 3D printing approaches. a Petri dish with a 2D cell monolayer under quasi-static fluidic conditions. b Single-layer microfluidic system with a 2D cell monolayer. Fluidic shear stress can be applied to cells seeded in the microchannel. c Multilayer microfluidic system with a 2D cell monolayer on an intervening porous membrane. Fluidic shear stress can be applied to cells seeded in the upper chamber, with quasi-static fluid in the lower chamber to represent the interstitial space. d Tubular porous membrane with a 3D cell monolayer.
Fluidic shear stress can be applied to cells seeded within the tubular membrane, with quasi-static fluid outside to represent the interstitial space. e Stereolithography (SLA). Focused light induces localized photopolymerization (white) of a photocurable material (blue) to fabricate 3D structures. f Extrusion-based printing. Material is extruded through a nozzle and deposited to fabricate 3D structures. g PolyJet Printing (PJP)/ MultiJet Modeling (MJM). Multiple inkjets in parallel deposit microdroplets of photocurable material and sacrificial support material simultaneously to fabricate 3D structures platform included a thin polyester membrane sandwiched between an enclosed upper PDMS microchannel and a lower PDMS well exposed to static media in a 35-mm culture dish. Fluidic shear stress applied to MDCK cells (seeded in the upper chamber on the 2D porous membrane) induced cell polarity, as evidenced by the expression of the apical water channel protein, aquaporin-2 (AQP2), and basolateral Na/K ATPase. Immunohistochemical staining confirmed that fluidic shear stress prompted improved cytoskeletal reorganization, focal adhesions, and cell junctions. Similar to in vivo physiology, the addition of vasopressin to the basolateral channel resulted in increased apical chamber osmolarity. Furthermore, the addition of aldosterone to the basolateral channel resulted in decreased sodium concentration sampled in the apical chamber [43] . Due to heterogeneity and limitations intrinsic to MDCK cell populations [59] , Jang and Suh et al. applied a structurally identical device to investigate the behavior of rat primary inner medullary collecting duct (IMCD) cells [44] . Apical AQP2 trafficking was associated with vasopressininduced F-actin depolymerization; however, in the absence of vasopressin, fluidic shear stress alone induced F-actin depolymerization and AQP2 translocation [44] .
Subsequent models have focused primarily on the proximal tubule [45••, 46-48] . In a functional nephron, numerous filtered substances in the intraluminal compartment require reabsorption, while various substances retained in the bloodstream require secretion into the lumen. Armed with solute selective transporters and AQP1 water channels on the apical membrane, the proximal tubule iso-osmotically reabsorbs 65 % of water, sodium, and chloride, 90 % of bicarbonate, and 100 % of glucose and amino acids from the glomerular filtrate [60] . Basolateral influx of organic acids and bases, via organic anion transporters (OATs) and organic cation transporters (OCTs) coupled to apical efflux through the multidrug resistance 1 (MDR1) gene product pglygoprotein 1 (Pgp), allowed for the excretion of xenobiotics and exogenous toxins. To model a number of these functions, Jang, Ingber and colleagues further adapted the aforementioned multilayer approach to create a proximal tubule-on-a-chip for drug toxicity testing using HK-2 cells [45••] . Proximal tubular toxicity to cisplatin-a known OCT2 ligand-was replicated and reversed with cimetidine-a known OCT2 inhibitor. Applied fluidic shear stress resulted in increased Pgp-mediated efflux, cell polarity, cilia expression, brush-border alkaline phosphatase activity, and albumin and glucose resorption [45••] . Using a similar multilayer, membrane-based architecture with an enclosed bottom channel (Fig. 1c) , Sciancalepore and Pisignano et al. cultured adult renal stem/progenitor cells (ARPCs) to model the proximal tubule [46] . The system included a porous polycarbonate membrane sandwiched between two identical PDMS microchannels. Consistent with prior work, applied fluidic shear stress promoted apical and basolateral localization of the AQP2 transporter and Na/K ATPase pump, respectively [46] .
To model the renal reabsorptive barrier, Frohlich, Charest, and colleagues adapted their prior methodology [58] to achieve a multilayer device with a topographically patterned porous polycarbonate membrane [47] . Consistent with the previous results [58] , HK-2 cells and primary renal proximal tubule epithelial cells (RPTECs) aligned in the direction of the groove lines [47] . Another multilayer system by Ferrell, Fissell, and colleagues included the integration of electrodes to measure the transepithelial electrical resistance (TEER) and assess cell junction integrity for both MDCK cells and RPTECs [48] . In response to applied fluidic shear stress, RPTECs revealed phenotypic changes, including disassembly of cytosolic F-actin stress fibers [48] .
Tubular Microfluidic Systems
In contrast to the aforementioned planar approaches, researchers have also explored new methodologies to better account for the local microcurvatures of in vivo kidney tubules. Wei, Nei, Bandyopadhyay, and colleagues developed a microfluidic device with a single, cylindrical microchannel by (i) fabricating a straight, rectangular microchannel and then (ii) executing a sol-gel-based protocol [61] for coating PDMS microchannels with glass approximately ten times in succession to resolve a circular channel cross-section [62•] . The transition to a circular microchannel enabled HK-2 cells to be seeded uniformly on the cylindrical walls, similar to in vivo physiology. The device lumen was subjected to increasing concentrations of calcium, resulting in a calcium phosphate product that was at supersaturation, and a demonstration of real-time calcium phosphate stone production within the tubular microfluidic platform [62•] . One drawback inherent to the glass-coated device, however, is that in vivo-like transport phenomena from the lumen to the interstitial space (e.g., those demonstrated with membrane-based systems [43, 44, 45••, 46-48] ) could not be recapitulated [62• ]. An alternative method to bypass this issue is the use of hollow tubular membranes (Fig. 1d) , such as those presented by Oo, Ying, Zink, and colleagues [63•] . In particular, Ng et al. designed a bioartificial kidney device in which a straight, tubular hollow-fiber membrane was embedded within a multicompartment microfluidic system [64] . The device architecture enabled fluid flow inside and outside the tubular membrane to be accessed independently. For cellular testing, the hollow tubular membranes were allowed to absorb bovine fibrinogen and perfused with bovine thrombin. Subsequent fibrin products cross-linked to form a sacrificial extracellular matrix (ECM), which supported the seeding of RPTECs. Experimental results demonstrated that inulin recovery could be used as a surrogate for the generation of a confluent monolayer of cells, as inulin moves across the cell layer in a paracellular fashion in regions without appropriate tight junctions [64] . Additional extensions of tubular kidney platforms that enable researchers to recreate local variations in tubule geometry (e.g., diameter and shape), global changes in tubule architecture (e.g., tortuosity), and tubuletubule and/or tubulo-vascular interfaces could further improve the biomimetic efficacy of in vitro approaches for modeling renal physiology.
Submillimeter-Scale 3D Printing
Although traditional methods of microdevice construction (e.g., soft lithography) afford significant benefits in terms of microscale precision and optical transparency, limitations inherent to such protocols remain a ubiquitous problem for biological applications [65] . A critical barrier for investigators outside of engineering fields is that gaining access to microfabrication facilities is often difficult and may require considerable technical training and high usage fees [66] . Furthermore, the clean room-based procedures for wafer processing are typically executed manually and can be exceedingly cost, time, and labor-intensive [67] . These issues are exacerbated when fabricating multilayer device designs that require distinct layers to be aligned and assembled manually [68] . The most crucial drawback for modeling in vivo physiology is that the monolithic restriction renders non-planar physical structures difficult or impossible to reconstitute via conventional micromachining processes. Consequently, alternative manufacturing methods capable of bypassing the aforementioned limitations could offer significant promise for diverse biological studies and applications.
Additive manufacturing-widely referred to as 3D printing-encompasses a number of methods for building 3D structures through point-by-point (PbP) and/or layer-by-layer (LbL) processes. Generally, computer-aided design (CAD) tools are used to generate a digital 3D model, which is then sent to a 3D printer for autonomous device construction. The first 3D printing technique-stereolithography (SLA), which was introduced by Hull-involves using a bath of liquidphase photoreactive material and a focused light beam to photocure (i.e., solidify) the material PbP, LbL, to ultimately fabricate a 3D object comprised of cured material (Fig. 1e ) [69] . Subsequently, Crump described an extrusion-based method in which a dispensing head or nozzle is used to directly deposit material PbP, LbL, to form 3D constructs (Fig. 1f ) [70] . Yamane et al. created a technique for building 3D structures by inkjet printing a photosetting or thermosetting material LbL [71] , which combined with the simultaneous printing of a sacrificial support material [72] , became the basis for 3D printing technologies including MultiJet Modeling (MJM) and PolyJet Printing (PJP) (Fig. 1g) . Although researchers have developed numerous 3D manufacturing methodologies for applications throughout broad academic and industrial fields, the submillimeterscale 3D printing techniques with characteristics relevant to kidney-on-a-chip systems stem from three fundamental approaches: (i) SLA, (ii) extrusion-based printing, and (iii) PJP/MJM (Table 2) .
Stereolithography-Based Microsystems
One of the first steps toward 3D printed microfluidics was the use of SLA processes to direct-write structures within prefabricated, single-layer PDMS microfluidic channels [73, 74] . By loading photocurable material into microfluidic channels, complex geometric structures can be photocured in situ to facilitate improved mixing dynamics [73] and multidirectional fluidic vias [74] . In recent years, however, researchers have utilized SLA to construct entire microfluidic systems [75] [76] [77] [78] [79] . For example, Shallan and Breadmore et al. demonstrated 3D microfluidic gradient and microdroplet generators constructed by means of digital-mirror device (DMD), projection-based SLA [75] . Au, Lee, and Folch evaluated the resolution of mail-order SLA-based microfluidic devices with rectangular microchannels and successfully cultured and imaged Chinese hamster ovary (CHO-K1) cells within the microfluidic devices [77] . Using similar SLA methods, Bhargava and Malmstadt et al. developed a number of discrete and reconfigurable elements consisting of microchannels with varying lengths (and therefore, resistances), which were utilized for microfluidic applications including mixing and droplet generation [76] . Subsequently, Au et al. presented 3D printed microfluidic systems with moving valves and pumps, which were employed to create a multi-fluid perfusion chamber for CHO-K1 cells [78] . In addition to constructing microfluidic systems, SLA can be used to build 3D cellular scaffolds. In particular, the Chen group has developed DMD-based continuous-projection SLA methods for creating hydrogel scaffolds for a variety of cellular studies [80] [81] [82] . Zhang et al. constructed 3D microstructured scaffolds and microwells using photocurable poly(ethylene glycol) diacrylate (PEGDA) and gelatin methacrylate (GelMA) materials [80] . Both human umbilical vein endothelial cells (HUVECs) and NIH-3T3 mouse embryonic fibroblast cells (3T3s) were cultured on the 3D scaffolds. Both cell types exhibited distinct morphology, and in some cases, multicellular structure, when grown on curvature when compared to 2D substrates [80] . Soman et al. constructed PEGDAbased Blog-pile^microarchitectures with varying mechanical stiffness to investigate the impact of mechanical stimuli on 3D motility of normal human mammary epithelial (HMLE) cells and cancerous, twist-transformed (HMLET) cells [81] . Using their well-printing methodology [80] , Hribar et al. built concave PEGDA microwells to culture BT474 breast cancer cell spheroids and induced pluripotent stem cell (iPSC) embryoid bodies (EBs) [82] . In response to microwell curvature, the iPSC EBs exhibited decreased polydispersity in size and maintained an undifferentiated state for an extended time, revealing potential roles of microscale geometry in iPSC functions [82] .
An extension of SLA in which multiphoton absorption is used for spatially controlled photopolymerization has enabled 3D manufacturing with resolutions down to the 100 nm range [83] . This technique-referred to as direct laser writing (DLW)-has been applied to create geometrically complex 3D cellular scaffolds [84, 85•, 86] . Using Ormocomp photoresist, Klein, Wegener, and Bastmeyer et al. applied DLW to construct web-like elastic scaffolds to measure the traction forces of seeded primary chicken embryonic cardiomyocytes (CECs) [84] . To control the formation of cell adhesion sites (and therefore, cell shape) for primary chicken embryonic fibroblasts (CEFs), the same group executed the DLW process twice in succession to create 3D composite-polymer scaffolds comprised of both Ormocomp and PEGDA to promote or prevent cell attachment, respectively [85•, 86] . To date, DLW has resulted in the finest resolutions for 3D cellular scaffold printing; however, this also limits the overall build size to the submillimeter range [84, 85•, 86] . One additional condition of note for SLA-based methods is that successful printing of many 3D designs requires the inclusion of fully integrated support structures (e.g., pillar-like ribs), which can be challenging or unfeasible to remove following the 3D printing process [87] .
Extrusion-Based Microsystems
The use of extrusion-based techniques for 3D Bbioprintingp rimarily revolves around the deposition of either sacrificial materials, such as fugitive inks, or cell-compatible materials, such as cell-laden gels. The Lewis group has pioneered a number of fugitive ink-based methods for resolving complex 3D microfluidic systems. To construct 3D vascular-inspired networks, Therriault et al. presented a four-step protocol: (i) micronozzles are used to 3D print a fugitive organic ink network, (ii) the fugitive ink scaffold is infiltrated with a surrounding liquid resin, (iii) the surrounding resin is cured, and (iv) heat is applied to the fugitive organic ink to enable vacuum-based extraction, thereby leaving behind a 3D network of hollow, interconnected microfluidic channels [88] . Wu et al. adapted this method by using the group's omnidirectional printing technique [89] to extrude free-floating fugitive ink within a reservoir of photopolymerizable hydrogel [90] . Following the printing process, the surrounding hydrogel was photocured, and the liquid-phase fugitive ink was evacuated via applied pressure. The resulting system included vascular-like microfluidic channels within a hydrogel matrix [90] . Using a similar approach, Miller and Chen et al. first printed a sacrificial 3D carbohydrate glass lattice, but instead encapsulated the 3D network with living cells and ECM [91] .
The full construct was then placed in cell media, which dissolved the carbohydrate glass filaments, thereby allowing for the remaining fluid to be replaced by fresh medium and/or suspended cells. The resulting scaffold supported viability for HUVECs, 10T1/2 mouse fibroblasts, 3T3s, human embryonic kidney (HEK 293T) cells, and primary rat hepatocytes [91] .
Extrusion-based deposition of cell-compatible materials and/or cell-laden gels represents the most widely used approach for 3D bioprinting of cellular constructs [92-95, 96••] . Recently, Rutz and Shah et al. used micronozzles to extrude poly(ethylene glycol) succinimidyl valerate (PEG SVA) and GelMA to 3D print self-supporting cross-hatched structures embedded with HUVECs, human dermal fibroblasts (HDFs), and human mesenchymal stem cells (hMSCs) [94] . Using a coaxial nozzle, Gao and He et al. printed cellular constructs comprised of hollow, cell-laden calcium alginate . The key limitation inherent to the extrusion-based methodologies is that the materials must be deposited PbP by a physical extruder (e.g., nozzle). As a result, not only does the printing process require comparatively more time, but also fabricating complex geometries can be especially challenging. Nonetheless, no other 3D printing approaches at present have had as much impact on 3D biomanufacturing or enabled as much flexibility in cellular placement, material selection, and heterogeneous cellular interactions as extrusion-based methods.
Polyjet/Multijet Modeling-Based Microsystems
PJP and MJM technologies utilize high numbers of microscale inkjets in parallel to deposit microdroplets of either a photopolymer or a sacrificial support material via a LbL process (with continual curing) to produce 3D objects. After printing completion, the support material can be removed during post-processing. Although these methods provide considerable advantages in terms of resolution, build volumes, print speeds, and sacrificial supports, PJP/ MJM material selection remains limited to a very small number of proprietary materials. Due to this lack of material versatility, such methods are not yet well-suited for many cellular applications. An initial work by Anderson and Spence et al. demonstrated that PJP-based millifluidic systems could be used for drug transport studies by first culturing bovine pulmonary artery endothelial (BPAE) cells to confluence on external (non-printed) cell culture membranes, which were then inserted into a designated slot in a 3D printed system [97] . Researchers have also applied MJM technologies to construct fluidic channels with varying geometries [98, 99] . To compare the efficacy of MJM technologies to SLA methods, Zhu and Wlodkowic et al. constructed a number of identical fluidic systems for arraying and imaging zebrafish embryos [100] . Despite successful fluidic trapping performance, the majority of the MJM and SLA resins tested were found toxic and/or caused significant developmental abnormalities over the course of multi-day experiments, with an MJM material, Visijet M3 Crystal, exhibiting the worst performance in terms of biotoxicity [100] .
Conclusion
The development of kidney-on-a-chip platforms capable of accurately mimicking the diversity of in vivo environmental conditions and physiological compositions offers significant potential for biomedicine, particularly for better understanding organ biology and establishing structures that can replace function. To accomplish these goals with respect to the kidney, future kidney-on-a-chip systems will require added complexity to simultaneously reconstitute five fundamental tiers of renal physiology: (i) fluidic conditions associated with tubular flow, (ii) cell-matrix interactions associated with tubular microenvironments (e.g., ECM and growth factors), (iii) biophysical characteristics associated with tubular microenvironments, including mechanical stiffness and porosity, (iv) multiscale geometric features of individual kidney tubules, such as local and global microcurvature and size, and (v) cell-cell and tissue-tissue interfaces stemming from the structural organization of discrete kidney tubules adjacent not only to other tubules but also to vasculature and other relevant cell types. This next generation of kidney-on-a-chip devices will demand significant advancements in biomanufacturing methodologies, such as those afforded by emerging micro/nanoscale 3D printing processes. Although individual 3D printing techniques each provide distinct benefits for recreating finite units of physiologic structures and/or functions, no singular method yet encompasses the full array of capabilities required to accurately recapitulate in vivo kidney physiology. Nonetheless, current micro/nanoscale 3D printing approaches offer numerous advantages over traditional microfabrication methodologies, and thus, future research should focus on transitioning toward 3D printed kidney-on-achip platforms.
